Abbreviations: BAEPs ϭ brainstem auditory evoked potentials; CMAP ϭ compound motor action potentials; EA ϭ episodic ataxia; MCV ϭ Motor conduction velocity; PCR ϭ polymerase chain reaction; SAP ϭ sensory action potentials; SCV ϭ sensory conduction velocity; SEPs ϭ somatosensory evoked potentials
Introduction
Autosomal dominant episodic cerebellar ataxias are characrespond to acetazolamide treatment. Interictally, nystagmus and other mild cerebellar signs are present (Gancher and terized by recurrent episodes of ataxia of variable duration. They are clinically and genetically heterogeneous disorders. Nutt, 1986; Baloh and Winder, 1991; Bain et al., 1992) . Vermian atrophy has been found at MRI (Vighetto et al. , In episodic ataxia type 1 (EA1), due to mutations at the KCNA1 gene on chromosome 12p13 (Browne et al., 1994; 1988) . In some cases, the disease may progress to a severe persistent cerebellar ataxia (Gancher and Nutt, 1986) . Litt et al., 1994) , patients experience brief episodes of ataxia and dysarthria, often accompanied by neuromyotonia or EA2 shows highly variable features, such as age at onset, frequency and duration of attacks, triggering stimuli and myokymia, and show, interictally, spontaneous myokymia arising from peripheral nerves (Gancher and Nutt, 1986) . In constellation of signs during attacks (Moon and Koller, 1991) . In some cases episodes appear to have a stronger vestibular episodic ataxia type 2 (EA2), also known as acetazolamideresponsive paroxysmal cerebellar ataxia, or vestibulocomponent being triggered by quick head movements or postural changes and accompanied by vertigo, nausea and cerebellar ataxia, affected individuals have longer episodes, lasting from minutes to days, characterized by attacks of vomiting. In others, episodes are characterized by a diffuse cerebellar syndrome triggered mainly by physical and vertigo, visual disturbances, dysarthria and ataxia, which emotional stress (Farmer and Mustian, 1963; White, 1969;  was extracted according to standard procedures, and typed, by polymerase chain reaction (PCR) amplification, for Donat and Auger, 1979; Gancher and Nutt, 1986; Friedman and Hollman, 1987; von Brederlow et al., 1995) . The gene CHLC (Cooperative Human Linkage Centre) and Généthon microsatellite markers spanning a 19p13 interval of~21 responsible for EA2 has recently been mapped to chromosome 19p13 (Kramer et al., 1995; Vahedi et al., cM: tel-D19S391-D19S413-D19S204-D19S394-D19S221-D19S226-D19S179-D19S410-D19S215-cen. The map order 1995; von Brederlow et al., 1995) in a region of~11-12 cM with a distal boundary at locus D19S413 (Kramer et al., was obtained by comparing CHLC and Généthon genetic maps (see also von Brederlow et al. 1995) as well as the 1995) and a proximal boundary at locus D19S226 (Kramer et al., 1995; von Brederlow et al., 1995) . chromosome 19 physical map (Ashworth et al., 1995) , placing D19S179 proximal to D19S226. We identified a large Italian kindred with acetazolamideresponsive episodes of ataxia with late onset, a marked PCR was performed according to methods already described (Sabbadini et al., 1995) . Two-point and multipoint vestibular component and a high frequency of cerebellar anomalies at MRI. The genetic study of the family showed linkage analyses were performed using the LINKAGE package (Lathrop et al., 1984) and, assuming four classes of strong evidence of linkage to markers of the 19p13 region, confirming its homogeneity with previous EA2 families, and age-dependent penetrances (i.e. 0.167, 0.417, 0.750 and 0.950 for ages ഛ24, 25-34, 35-44 and ജ45 years, respectively), it provided a further refinement of the EA2 gene mapping.
derived from the cumulative distribution of age at disease onset in the family. Alleles were reduced according to Ott (1978) . Allele
Subjects and methods
The family ( Fig. 1 ) is of Italian origin (Campania) with frequencies for CHLC markers (D19S391, D19S204, S19S394, D19S179) were those observed in 70 independent evidence of the disease over three generations. Fifty-two family members over 18 years of age were neurologically chromosomes from the present and other Italian families (data not shown). For the remaining markers, belonging to examined by at least two of the authors. Interictal cerebellar signs were scored according to the rating scale of Klockgether the Généthon set, the frequencies were those reported in GDB (The Genome Data Base), although different allele et al . (1990) with the addition of a score for oculomotor findings based on the disease evolution observed in the names were used in Fig. 1 . The frequency of the disease allele was set at 0.0001. present family (normal ϭ 0, saccadic pursuit and reduction of optokinetic response ϭ 1, nystagmus in the extreme lateral/vertical gaze ϭ 2, nystagmus in intermediate lateral/ vertical gaze ϭ 3). Sixteen subjects underwent MRI,
Results
performed on a 0.5 Tesla superconductive magnet (General Electric, Fairfield, Conn., USA) with T 1 (TR ϭ 650, TE ϭ
Case reports and clinical examination
Patient IV-24, the index case, was first seen at 48 years of 25) and T 2 (TR ϭ 650, TE ϭ 25) spin-echo pulse sequences. T 1 -weighted images of the posterior fossa were acquired on age because of a progressive cerebellar syndrome with onset at the age of 42 years and a family history of balance the axial and sagittal plane at a slice thickness of 5 mm, and T 2 -weighted images of the whole brain on the axial plane at impairment. At examination he showed ataxic gait, marked cerebellar nystagmus, dysmetria, limb tremor and dysarthria. a slice thickness of 10 mm. Vermian atrophy was diagnosed when a reduction of the vermis image against the cisterna Electrophysiological examination (BAEP, SAP, SEP, SCV, MCV, CMAP) was normal. At MRI ( Fig. 2 ) a cerebellar magna was present in the sagittal plane, and atrophy of cerebellar hemispheres on the basis of foliation visible on atrophy, mainly of vermis, was evident without truncal involvement. The patient had had short vertigo episodes the axial plane. The degree of atrophy was qualitatively subdivided as follows: normal ϭ 0; mild upper vermis during the 9-year period preceding the impairment of balance. Patient IV-2 had episodes of dizziness since the age of 35 atrophy ϭ 1; mild upper and lower vermis atrophy ϭ 2; moderate upper and lower vermis atrophy ϭ 3; severe years, lasting a few seconds and triggered by postural changes such as raising himself from bed. The episodes became more vermian atrophy and moderate hemisphere atrophy ϭ 4; severe diffuse cerebellar atrophy ϭ 5. frequent (several times per day) over the next few years and were accompanied by true vertigo and inability to stand up Neurophysiological examination was conducted using a Medelec Sapphire 2ME apparatus (Surrey, UK). Motor without support. These episodes were followed by difficulties in speaking and walking lasting several minutes. Five years conduction velocity (MCV), compound motor action potentials (CMAPs), sensory conduction velocity (SCV), after the onset he noted a progressive gait imbalance which limited his daily activities, as well as dysarthria. An MRI sensory action potentials (SAP), somatosensory evoked potentials (SEPs) and brainstem auditory evoked potentials performed when he was aged 57 years showed a vermian cerebellar atrophy. He was seen for the first time by our (BAEPs) were obtained according to methods reported by Kimura (1989) .
group at the age of 60 years, and presented marked cerebellar deficits (see Table 1 ). Neurophysiological (BAEP, SAP, SEP, Fifty-two members and nine spouses married into the family gave blood samples upon informed consent. DNA SCV, MCV, CMAP) and audiovestibular examinations were identify the stimuli. They were characterized by vertigo, oscillopsia and cerebellar signs limited to an inability to stand up or walk and dysarthria. No inaccuracy or incoordination in upper limb movement was reported. The attack observed by one of the authors in Patient V-1 was mainly characterized by vertigo and nystagmus without other symptoms. Eleven of the 13 patients had interictal ataxia of various degrees and the two patients with shorter disease duration had interictal nystagmus and a mild tremor only. No impairment of other neurological systems was present. All the 11 patients undergoing MRI (Table 1) had vermian with or without hemisphere cerebellar atrophy. Six had migraine without aura. A few family members showed atypical neurological signs. Subject III-12, aged 70 years, reported only one episode of vertigo lasting a few days, but had no interictal signs. Subject IV-4, aged 57 years, with a history of alcohol abuse, presented with uncertain gait, intentional tremor and a diffuse cerebral atrophy at MRI. Subject IV-19, aged 44 years, with a history of migraine, reported several episodes of dizziness but had no definite interictal signs. These three subjects were considered as having an undefined phenotype.
The effect of acetazolamide treatment could be reliably evaluated in seven patients only (Table 2) , since the others had a very poor compliance with drug-taking. In all of them the treatment was highly effective in reducing the frequency and duration of episodes, while showing only a mild improvement of the permanent cerebellar signs.
Genetic study
The result of two-point linkage analyses between the disease and nine microsatellite markers of the 19p13 region are reported in Table 3 . Highly positive lod scores were obtained with markers proximal to D19S221. When subjects with undefined phenotypes were considerd as affected, somewhat lower, but still highly positive lod scores were obtained (e.g. D19S226 maxlod ϭ 2.65, theta 0.11). Multipoint linkage analysis with the disease locus against a fixed map D19S413-cM6-D19S221-cM12-D19S215 provided 910:1 odds in favour of a disease gene location proximal, rather than distal, to D19S221 (Fig. 3) . some recombining with the normal paternal haplotype distal to D19S226. The recombinant chromosome was passed on to her 28-year-old healthy son, whose residual risk of normal. A new MRI scan performed 3 years after the previous one showed that atrophy had extended to the cerebellar manifesting the disease later on is~0.60. A new blood sample and a neurological rexamination of Subject IV-10 confirmed hemispheres. Treatment with 250 mg/day acetazolamide completely resolved the daily episodes and only slightly previous findings. This crossover sets a new distal boundary for the EA2 gene-containing region at D19S221, which maps improved the cerebellar signs.
Overall, out of the 52 examined, 13 family members were 6 cM proximal to D19S413 (distal boundary set by Kramer et al., 1995) and 8 cM proximal to D19S391 (distal boundary found to have a clear history of repeated vertigo episodes, always beginning in adulthood (Table 1 ). Age at onset seemed set by von Brederlow et al., 1995) . Further support to a location proximal to D19S221 comes from the complementary to show a tendency toward anticipation along generations. The attacks, as reported by patients, were mostly triggered crossover in Subject IV-13 who carries the normal chromosome recombined with the distal part of the disease-associated by postural changes, except for three subjects who could not Oculomotor findings  2  2  3  3  3  3  2  3  3  3  2  2  2  Intention tremor  2  1  4  4  1  3  2  3  3  2  2  1  1  Dysarthria  1  2  4  3  1  3  2  3  4  3  1  0  0  Dysdiadochokinesis  2  2  4  4  2  3  2  3  4  3  1  0  0  Upper limb ataxia  1  2  3  3  2  2  2  3  3  2  1  0  0  Lower limb ataxia  2  3  4  3  1  2  1  3  4  1  1  0  0  Ataxia of stance  1  2  3  3  2  3  1  3  3  1  1  0  0  Ataxia of gait  1  2  3  3  1  2  1  3  4  2  1  0  0  Total score:  12  16  28  26  13  21  13  24  28  17  10  3  3   Cerebellar atrophy (MRI)  2  3  4  4  NP  3  3  NP  4  3  2  1  1 Dϭdaily; W ϭ weekly; h ϭ hours (Ј ϭ minutes); ϩ ϭ present; Ϫ ϭ absent; NP ϭ not performed. See text for scoring system. haplotype including D19S221. This subject has no sign of disease chromosome recombining with the normal maternal haplotype distal to D19S221, which is passed on to the the disease at the age of 38 years and her residual risk of having the disease is~0.25. Finally, patient IV-8 carried a affected daughter V-7 with the normal maternal allele at (Kramer et al., 1995; Vahedi et al., 1995; von Brederlow et al., 1995) , the present family showed attacks with a more definite vestibular component, being triggered by quick movements or postural changes and characterized by vertigo and oscillopsia with cerebellar signs limited to dysarthria and gait ataxia. Acetazolamide-responsive episodic ataxia displays a wide variability of signs and symptoms during attacks (Moon and Koller, 1991) . Some authors distinguish two different types of EA2: a vestibulocerebellar one, with episodes similar to those in the present family, and a 'diffuse cerebellar syndrome', in which both trunk and limb ataxia are present during the episodes while vertigo is infrequent (Farmer and Mustian, 1963; Baloh and Winder, 1991; von Brederlow et al., 1995) . The latter form is more similar to that found in previous families with linkage to the 19p markers. However, Donat and Auger (1979) reported both to be considered as a variable expression of the same gene mutation. In the present family with the vestibulocerebellar locus D19S215. This crossover sets the proximal limit of type, the linkage of the disease to 19p13 markers further the candidate interval in our family, but does not refine the supports the hypothesis that the two types are due to the previous proximal boundary at D19S226 (Kramer et al., same gene. 1995; von Brederlow et al., 1995) . It is Another distinctive feature of this family is the onset of notable that the three subjects with undefined phenotypes are the disease in middle/late adulthood, while the families on not carrying the disease haplotype. In fact, their atypical which the disease gene was previously mapped had an onset features could be ascribed to different causes such as anxiety in infancy or adolescence (Kramer et al., 1995; von Brederlow or migraine equivalents (IV-19) , alcoholism (IV-4) and an et al., 1995). However, a late age of onset is also reported occasional vestibular impairment .
Table 2 Evaluation of acetazolamide in seven patients, comparing the ictal and interictal signs prior to and during treatment
by Farmer and Mustian (1963) and Farris et al. (1986) . A final aspect worth considering in these patients is the high frequency of MRI anomalies. No neuroimaging study Discussion as extended as the present one was performed in the families A large Italian family with an autosomal dominant previously reported. Atrophy of cerebellar vermis has been acetazolamide-responsive episodic ataxia linked to 19p13 documented in three patients with episodic ataxia and markers is reported. Patients showed repeated attacks of interictal nystagmus by Vighetto et al. (1988) . However, vertigo and unsteadiness lasting from minutes to hours, and, interictally, cerebellar signs of variable severity (from patients with normal MRI or CT scans are also reported occasionally (Zasorin et al., 1983; Baloh and Winder, 1991 ; BMH1 CT941243 to M.F., and by a grant from Fondazione per la Ricerca sull'Epilessia to M.M. Vahedi et al., 1995) . The atrophy of cerebellar vermis, therefore, appears to be a variable feature of the disease, but our findings seem to indicate that it is more frequent than previously thought, assuming identical criteria for the
